Cargando…

1895. The Anti-Parasitic Drug Atovaquone Inhibits Arbovirus Replication

BACKGROUND: Atovaquone, a hydroxynaphthoquinone, FDA Pregnancy category C, used for the treatment and prevention of pneumocysits jirovecii pneumonia (PCP), toxoplasmosis, babesiosis and malaria has in vitro activity against Zika virus (ZIKV). The mechanism of action against Plasmodium spp. and other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kottkamp, Angelica, DeJesus, Elfie, Stapleford, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254043/ http://dx.doi.org/10.1093/ofid/ofy210.1551

Ejemplares similares

Atovaquone and Berberine Chloride Reduce SARS-CoV-2 Replication In Vitro
por: Rodriguez-Rodriguez, Bruno A., et al.
Publicado: (2021)

1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
por: Aleissa, Muneerah, et al.
Publicado: (2019)

Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity
por: Rijpma, Sanna R, et al.
Publicado: (2014)

525. Atovaquone for Treatment of COVID-19 (Ataq COVID-19) Trial
por: Jain, Mamta K, et al.
Publicado: (2021)

Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito
por: Balta, Victoria A., et al.
Publicado: (2023)

1137. Implementation of Universal Screening for Strongyloidiasis Among Solid-Organ and Hematopoietic Stem Cell Transplantation Candidates in a Non-endemic Area
por: Kottkamp, Angelica, et al.
Publicado: (2018)

2696. Breakthrough Toxoplasmosis While on Atovaquone Prophylaxis Following Allogeneic Hematologic Stem Cell Transplantation
por: Chueng, Teresa A, et al.
Publicado: (2019)

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
por: Ashton, Thomas M., et al.
Publicado: (2016)

Antimalarial pharmacology and therapeutics of atovaquone
por: Nixon, Gemma L., et al.
Publicado: (2013)

Reproducciones (1895)
por: Ferrel, José

The anti-malarial drug atovaquone potentiates platinum-mediated cancer cell death by increasing oxidative stress
por: Coates, James T. T., et al.
Publicado: (2020)

145 Arbovirus and related infection disease in China
por: Liang, Guodong
Publicado: (2014)

1895. Serious Antibiotic-Related Adverse Effects Following Unnecessary Dental Prophylaxis in the United States
por: Gross, Alan E, et al.
Publicado: (2019)

1895. Omadacycline for the Treatment of Non-Pulmonary Mycobacterial Infections: a Single-Center Retrospective Review
por: Shen, Edmund, et al.
Publicado: (2023)

Annus Medicus, 1895
Publicado: (1896)

Population Statistics for 1895
Publicado: (1897)

High-throughput detection of eukaryotic parasites and arboviruses in mosquitoes
por: Cannon, Matthew V., et al.
Publicado: (2021)

Potent inhibition of tumour cell proliferation and immunoregulatory function by mitochondria-targeted atovaquone
por: Cheng, Gang, et al.
Publicado: (2020)

Atovaquone/proguanil‐induced autoimmune‐like hepatitis
por: Terziroli Beretta‐Piccoli, Benedetta, et al.
Publicado: (2017)

Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone
por: Makino, Takahiro, et al.
Publicado: (2017)

Oxidative stress induced by the anti-cancer agents, plumbagin, and atovaquone, inhibits ion transport through Na(+)/K(+)-ATPase
por: Alharbi, Yousef, et al.
Publicado: (2020)

Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments
por: Akazawa, Daisuke, et al.
Publicado: (2023)

Hans Kopfermann (1895-1963)
por: Weisskopf, Victor Frederick
Publicado: (1964)

Results of Hospital Sunday, 1895
Publicado: (1895)

The Year-Book of Treatment for 1895
Publicado: (1895)

The Year-Book of Treatment for 1895
Publicado: (1895)

Mississippi Dental Association, 1895
por: Walker, J. M.
Publicado: (1895)

Louis Pasteur.—1822–1895
Publicado: (1895)

The Physician’s Visiting List for 1895
Publicado: (1894)

International Medical Annual for 1895
Publicado: (1895)

The SUMOylation pathway suppresses arbovirus replication in Aedes aegypti cells
por: Stokes, Samuel, et al.
Publicado: (2020)

DIPG-09. ATOVAQUONE RADIOSENSITISES DIFFUSE MIDLINE GLIOMAS BY INHIBITING MITOCHONDRIAL METABOLISM AND HYPOXIA
por: Mudassar, Faiqa, et al.
Publicado: (2023)

Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
por: Sutherland, Colin J, et al.
Publicado: (2008)

Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene
por: Afonso, Ana, et al.
Publicado: (2010)

Plasmodium falciparum Malaria and Atovaquone-Proguanil Treatment Failure
por: Durand, Rémy, et al.
Publicado: (2008)

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
por: Bakshi, Rahul P., et al.
Publicado: (2018)

Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria
por: Blanshard, Andrew, et al.
Publicado: (2021)

Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers
por: Kapur, Arvinder, et al.
Publicado: (2022)

Tolerability of Atovaquone—Proguanil Application in Common Buzzard Nestlings
por: Wiegmann, Anja, et al.
Publicado: (2022)

Role of Cellular Lipids in Positive-Sense RNA Virus Replication Complex Assembly and Function
por: Stapleford, Kenneth A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_erjib0od456o2vpr8pdvlteo04